Related Experiment Video
Updated: May 28, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Fixed Drug Eruption due to Iopromide (Ultravist®)
Sang Hee Cha1, Hei Sung Kim, Jun Young Lee
1Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Abstract:
A 69-year-old male presented with several painful erythematous patches on both palms and trunk several days after receiving iopromide (Ultravist®, Shering, Berlin, Germany). A fixed drug eruption (FDE) due to iopromide was suspected clinically. However, at that time, the patch test with iopromide at the lesion site gave negative results. Three years later, the patient was mistakenly administered iopromide again and patches with vesicles recurred on the same sites as well as on the genitalia. This episode was repeated once again after 1 year. In all episodes, the skin lesion resolved after application of topical steroids. Although a patch test with iopromide was negative in our case, we made a diagnosis of FDE due to iopromide because the skin lesions occurred again at the previously involved area after re-exposure to iopromide. To date, only three cases of FDE caused by non-ionic monomers have been documented in the English literature. Herein, we report on an interesting case of FDE caused by iopromide.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Allergic Drug Reactions
Ophthalmic Drug Delivery Systems
Drugs for Treatment of Constipation-Predominant IBS
Drug toxicity: Idiosyncratic Reactions
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
